Sign in
Taking peopleNo phase

Catheter device Acostream for serious blood clots in the lungs

Tests Acostream, a catheter suction device, in adults with serious pulmonary embolism.

Key facts

Who runs it
RenJi Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism
Status
Recruiting
People taking part
127 people, planned
Started
1 Apr 2025
Expected to end
31 Dec 2026
Type of study
Interventional
Treatments tested
  • Acostream aspiration
Record updated
27 April 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with high-risk or intermediate-high-risk sudden blood clots in the lungs (pulmonary embolism). It tests clot removal through a thin tube using the Acostream device.

Age
18 to 85 years
Sex
All sexes
Disease stage
Acute pulmonary embolism with symptoms for 14 days or less. High-risk patients, or intermediate-high-risk patients with a strained right side of the heart (right ventricle/left ventricle >0.9) seen on a CT scan of the lung vessels or a heart ultrasound.
Earlier treatment
High-risk patients must be unable to have clot-dissolving drugs given through a vein, or these drugs did not work (ongoing circulatory collapse). They also must not be able to have surgery to remove the clot.
Biomarker or test result
For intermediate-high-risk patients: right ventricle/left ventricle >0.9 on computed tomography pulmonary angiography or transthoracic echocardiography.

Main reasons for not taking part

  • Pregnancy
  • A blood clot inside the heart
  • Long-term left heart failure with ejection fraction lower than 30%, or a diagnosed tendency to form blood clots (thrombophilia)
  • History of severe or long-term high blood pressure in the lungs
  • Serum creatinine higher than 1.8 mg/dl (159 µmol/L), or known serious uncontrolled sensitivity to X-ray contrast agents

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • 18≤Age≤85
  • Clinical symptoms and presentation consistent with pulmonary embolism (PE)
  • PE symptoms duration ≤ 14 days
  • High risk PE patients with absolute contraindications to systemic thrombolysis or its failure (refractory circulatory collapse) not eligible for surgical embolectomy
  • Intermediate-high risk PE patients with right ventricle dysfunction (right ventricle/ left ventricle >0.9) confirmed by computed tomography pulmonary angiography or transthoracic echocardiography

Who cannot take part

  • History of severe or chronic pulmonary hypertension
  • Presence of chronic left heart failure with an ejection fraction lower than 30% Diagnosed thrombophilia
  • Serum creatinine level higher than 1.8 mg/dl
  • Pregnancy
  • Refusal to sign the informed consent form
  • Presence of intracardiac thrombus
  • Known serious and uncontrolled sensitivity to radiographic agents

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The registry is to evaluate the safety and feasibility of catheter-directed aspiration for patients with high-risk and intermediate-high-risk pulmonary embolism using Acostream.

The group in the trial

  • The Acostream aspiration groupTreatment being tested

    The pulmonary thrombus removal by Acostream.

    Treatment: Acostream aspiration

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism (The ARTIST Study)
Plain-language title
Catheter device Acostream for serious blood clots in the lungsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06946732, who can take part
Record updated
27 April 2025